ArticleFrontiers in oncology2023

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.

Rao Prabhala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.